• Disrupted brain state dynamics in opioid and alcohol use disorder: attenuation by nicotine use
  Published on 2023-11-06
  2 years ago
• Comparable roles for serotonin in rats and humans for computations underlying flexible decision-making
  Published on 2023-10-31
  2 years ago
• A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms
  Published on 2023-10-29
  2 years ago
• Bed Nucleus of the Stria Terminalis (BNST) neurons containing the serotonin 5HT2c receptor modulate operant alcohol self-administration behavior in mice
  Published on 2023-10-26
  2 years ago
• Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study
  Published on 2023-10-24
  2 years ago
• Navigating the FDA regulatory landscape
  Published on 2023-10-18
  2 years ago
• Psychosocial moderators of polygenic risk scores of inflammatory biomarkers in relation to GrimAge
  Published on 2023-10-17
  2 years ago

« Previous 1 … 58 59 60 61 62 … 143 Next »

• The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder
  Published on 2022-02-25
  3 years ago
• Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine
  Published on 2022-02-25
  3 years ago
• A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults
  Published on 2022-02-15
  3 years ago
• LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking
  Published on 2022-02-02
  3 years ago
• Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
  Published on 2022-02-02
  3 years ago
• Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats
  Published on 2022-02-01
  3 years ago
• Clinical effects of glabellar botulinum toxin injections on borderline personality disorder: A randomized controlled trial
  Published on 2022-02-01
  3 years ago

« Previous 1 … 58 59 60 61 62 … 124 Next »

• Early intervention and staging bipolar disorder: Conceptual and clinical dilemmas
  Published on 2022-07-27
  3 years ago
• Non-prescribed use of gabapentinoids: Mechanisms, predisposing factors, associated hazards and clinical management
  Published on 2022-07-27
  3 years ago
• Erratum to “Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100–116]”
  Published on 2022-07-24
  3 years ago
• Comment to “Requiem or resurrection: Classic monoamine oxidase inhibitors revisited”
  Published on 2022-07-24
  3 years ago
• A polygenic-informed approach to a predictive EEG signature empowers antidepressant treatment prediction: A proof-of-concept study
  Published on 2022-07-24
  3 years ago
• Associations between oxidative stress markers and patient-reported smartphone-based symptoms in patients newly diagnosed with bipolar disorder: An exploratory study
  Published on 2022-07-24
  3 years ago
• The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders
  Published on 2022-07-24
  3 years ago

« Previous 1 … 58 59 60 61 62 … 145 Next »